MedTrace Logo

Single Dose Steroid Before Thyroidectomy for Benign Disease to Improve Postoperative Nausea, Pain, and Vocal Function

NCT00888303 · Status: UNKNOWN · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 80

Last updated 2012-09-05

No results posted yet for this study

Summary

The purpose of this study is to evaluate the efficacy of 8 mg of dexamethasone administered prior surgery, to reduce pain, postoperative nausea and vomiting and to improve vocal function after thyroidectomy for benign disease.

Conditions

  • Postoperative Pain
  • Postoperative Nausea and Vomit
  • Postoperative Vocal Function
  • Thyroidectomy

Interventions

DRUG

Dexamethasone

20 minutes before total or partial thyroidectomy for benign disease a single dose of intravenous 8 mg/2mL of dexamethasone is administered

DRUG

saline solution

20 minutes before total or partial thyroidectomy for benign disease 100 mg of saline solutions are administered intravenous

PROCEDURE

Thyroidectomy, total or partial

Surgical standard intervention

Sponsors & Collaborators

  • Ospedale Misericordia e Dolce

    lead OTHER

Principal Investigators

  • Marco Scatizzi, MD · Misericordia and Dolce Hospital

  • Marco Rettori, MD · Misericordia and Dolce Hospital

  • Francesco Feroci, MD · Misericordia and Dolce Hospital

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2009-01-31
Primary Completion
2012-10-31
Completion
2012-10-31

Countries

  • Italy

Study Locations

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00888303 on ClinicalTrials.gov